Compound Evidence File
#EC-2026-0693
PT-141(Bremelanotide)
Filed under Peptides. The bureau holds 188 laboratory returns for this compound from 54 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
54 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 27 Apr 2026 | 16 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 9.9 | 10.0 | 24 Nov 2025 | 22 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 10 Mar 2026 | 13 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 10 Mar 2026 | 17 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 10.0 | 10.0 | 9 Dec 2025 | 10 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 10.0 | 10.0 | 6 Nov 2025 | 3 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 13 Feb 2026 | 15 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 10.0 | 10.0 | 14 Jan 2026 | 15 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 10 Apr 2026 | 5 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 9.9 | 10.0 | 26 Jun 2026 | 22 Jul 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Jan 2026 | 1 Apr 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Mar 2026 | 27 May 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 14 May 2026 | 10 Aug 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 13 Mar 2026 | 1 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Dec 2025 | 5 Jul 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | A | 2 | 9.9 | 9.8 | 10.0 | 3 Oct 2025 | 3 Oct 2025 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 6 Apr 2026 | 25 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 1 Apr 2026 | 10 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 9 Feb 2026 | 4 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 9.9 | 25 Apr 2026 | 6 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Jul 2026 | 10 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 9.9 | 8 Apr 2026 | 17 Jul 2026 |
| PeptidologyCASE #VI-2026-0520 | A | 4 | 9.8 | 9.4 | 10.0 | 13 Jun 2025 | 11 Aug 2025 |
| UtherCASE #VI-2026-0902 | A | 2 | 9.8 | 9.7 | 10.0 | 9 Oct 2025 | 9 Oct 2025 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 9.5 | 9.0 | 9.9 | 18 May 2026 | 18 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 9.1 | 7.6 | 10.0 | 24 May 2026 | 24 May 2026 |
| Peptide SciencesCASE #VI-2026-0867 | A | 6 | 9.1 | 7.0 | 9.7 | 7 May 2025 | 12 Aug 2025 |
| Peptide TechnologiesCASE #VI-2026-0694 | A | 2 | 8.9 | 8.7 | 9.2 | 16 Mar 2025 | 16 Mar 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.5 | 7.4 | 9.6 | 24 May 2026 | 24 May 2026 |
| Qing Li PeptideCASE #VI-2026-0469 | A | 4 | 8.3 | 6.6 | 10.0 | 31 Jul 2025 | 29 Dec 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 8.1 | 7.4 | 8.7 | 23 May 2026 | 23 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | B | 6 | 8.1 | 5.6 | 10.0 | 19 Aug 2025 | 24 May 2026 |
| Paramount PeptidesCASE #VI-2026-0550 | C | 3 | 8.0 | 4.7 | 9.8 | 25 Apr 2025 | 7 May 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 7.9 | 7.9 | 7.9 | 23 May 2026 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 7.8 | 6.6 | 8.9 | 25 May 2026 | 25 May 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | A | 6 | 7.4 | 6.7 | 9.0 | 6 Aug 2025 | 19 Aug 2025 |
| Planet PeptideCASE #VI-2026-0092 | A | 3 | 7.4 | 6.4 | 8.1 | 25 Apr 2025 | 7 May 2025 |
| Reta-PeptideCASE #VI-2026-0756 | C | 5 | 6.9 | 4.5 | 10.0 | 31 Aug 2025 | 15 Jan 2026 |
| Verified PeptidesCASE #VI-2026-0407 | B | 4 | 6.5 | 5.9 | 7.0 | 16 Mar 2025 | 7 May 2025 |
| Atomik LabzCASE #VI-2026-0327 | C | 4 | 6.5 | 4.2 | 8.6 | 7 May 2025 | 21 May 2025 |
| DeuschemCASE #VI-2026-0004 | D | 4 | 5.9 | 4.0 | 7.3 | 13 Jun 2025 | 4 Aug 2025 |
| Pure Tested PeptidesCASE #VI-2026-0225 | C | 2 | 5.8 | 5.5 | 6.0 | 26 Jan 2026 | 26 Jan 2026 |
| Biolabshop LimitedCASE #VI-2026-0832 | C | 2 | 5.8 | 4.3 | 7.3 | 13 Jun 2025 | 12 Aug 2025 |
| LiliPeptideCASE #VI-2026-0695 | E | 7 | 5.8 | 0.0 | 8.4 | 25 Sep 2025 | 19 May 2026 |
| Biolongevity LabsCASE #VI-2026-0442 | C | 3 | 5.7 | 4.2 | 7.0 | 13 Jun 2025 | 12 Aug 2025 |
| Nuscience PeptidesCASE #VI-2026-0554 | C | 2 | 5.7 | 5.7 | 5.7 | 7 May 2025 | 7 May 2025 |
| ScienceCASE #VI-2026-0636 | C | 2 | 5.7 | 5.6 | 5.8 | 21 May 2025 | 21 May 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | D | 2 | 5.2 | 3.2 | 7.2 | 7 May 2025 | 7 May 2025 |
| OupeptideCASE #VI-2026-0435 | X | 1 | 4.7 | 4.7 | 4.7 | 24 Jul 2025 | 24 Jul 2025 |
| Peptide GurusCASE #VI-2026-0854 | E | 3 | 3.0 | 2.9 | 3.2 | 16 Mar 2025 | 16 Mar 2025 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 2.5 | 2.5 | 2.5 | 16 Mar 2025 | 16 Mar 2025 |
| SRY LabsCASE #VI-2026-0657 | E | 2 | 2.2 | 1.8 | 2.5 | 26 Jun 2025 | 29 Jun 2025 |
Open any subject to view the batch-level evidence for PT-141(Bremelanotide) alone.